AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35230864 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous theta burst stimulation (cTBS)
Number of subjects: 0
Study 35230864 — intervention group
Group type: COMPARATOR
Intervention: Inhibitory theta burst stimulation (iTBS)
Number of subjects: 0
Study 32335132 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-minute RHD duration
Number of subjects: 450
Study 32335132 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-minute RHD duration
Number of subjects: 450
Study 32335132 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-minute RHD duration
Number of subjects: 450
Study 33029128 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS to the left DLPFC
Number of subjects: 55
Study 33649927 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP)
Number of subjects: 0
Study 33649927 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid (HA)
Number of subjects: 0
Study 33649927 — intervention group
Group type: EXPERIMENTAL
Intervention: Autogenous fat graft (AFG)
Number of subjects: 0
Study 33649927 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin (BTX)
Number of subjects: 0
Study 33649927 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagen
Number of subjects: 0
Study 33649927 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal wall injection
Number of subjects: 0
Study 33754861 — intervention group
Group type: EXPERIMENTAL
Intervention: Inoculated with Pythium myriotylum isolates (two 5-mm mycelial plugs from active growing cultures)
Number of subjects: 8
Study 33754861 — intervention group
Group type: COMPARATOR
Intervention: Control group (inoculated with blank PDA plugs)
Number of subjects: 8
Study 32776693 — intervention group
Group type: EXPERIMENTAL
Intervention: Break Binge Eating online platform
Number of subjects: 786
Study 33835051 — intervention group
Group type: EXPERIMENTAL
Intervention: UDCA + Mesalazine
Number of subjects: 40
Study 33835051 — intervention group
Group type: COMPARATOR
Intervention: Mesalazine
Number of subjects: 40
Study 34274495 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition and exercise intervention delivered by registered dietitians specializing in oncology nutrition and exercise training, consisting of goal setting to meet nutrition and physical activity guidelines for cancer survivors, over a yearlong period with 16 sessions.
Number of subjects: 172
Study 34274495 — intervention group
Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 172
Study 34274495 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition and exercise intervention
Number of subjects: 172
Study 32629506 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-min nap after sleep deprivation
Number of subjects: 11
Study 32629506 — intervention group
Group type: COMPARATOR
Intervention: Sleep deprivation
Number of subjects: 11
Study 32629506 — intervention group
Group type: COMPARATOR
Intervention: Normal sleep
Number of subjects: 11
Study 36224375 — intervention group
Group type: EXPERIMENTAL
Intervention: UPBEAT intervention (n = 31)
Number of subjects: 39
Study 36224375 — intervention group
Group type: COMPARATOR
Intervention: Standard care arm (n = 39)
Number of subjects: 39
Study 33283667 — intervention group
Group type: EXPERIMENTAL
Intervention: End-to-side anastomosis
Number of subjects: 100
Study 33283667 — intervention group
Group type: COMPARATOR
Intervention: Side-to-side anastomosis
Number of subjects: 100
Study 35981118 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (MBI), 8-week personalized yoga therapy.
Number of subjects: 45
Study 35981118 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned).
Number of subjects: 45
Study 33704052 — intervention group
Group type: EXPERIMENTAL
Intervention: Orally disintegrating film of varenicline salicylate (test drug)
Number of subjects: 28
Study 33704052 — intervention group
Group type: COMPARATOR
Intervention: Film‐coated tablets of varenicline tartrate (reference drug)
Number of subjects: 28
Study 32717999 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg mango leaf extract (Zynamite®)
Number of subjects: 70
Study 32717999 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 70
Study 33657755 — intervention group
Group type: EXPERIMENTAL
Intervention: WBV-30 (30 Hz, low amplitude)
Number of subjects: 14
Study 33657755 — intervention group
Group type: EXPERIMENTAL
Intervention: WBV-50 (50 Hz, low amplitude)
Number of subjects: 14
Study 33657755 — intervention group
Group type: COMPARATOR
Intervention: No-WBV
Number of subjects: 14
Study 33291798 — intervention group
Group type: EXPERIMENTAL
Intervention: Tryptamines (5‐MeO‐DiPT, 5‐MeO‐DALT, DMT)
Number of subjects: 0
Study 33291798 — intervention group
Group type: EXPERIMENTAL
Intervention: Analytical methods (liquid chromatography tandem mass spectrometry)
Number of subjects: 0
Study 35389303 — intervention group
Group type: EXPERIMENTAL
Intervention: Calendula officinalis L.
Number of subjects: 0
Study 32967390 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradiscal ozone therapy (Group 1)
Number of subjects: 65
Study 32967390 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradiscal ozone therapy with periforaminal steroid injection (Group 2)
Number of subjects: 65
Study 32967390 — intervention group
Group type: COMPARATOR
Intervention: Comparison between Group 1 and Group 2
Number of subjects: 65
Study 35916802 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofol
Number of subjects: 120
Study 35916802 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 120
Study 33220004 — intervention group
Group type: EXPERIMENTAL
Intervention: BAG
Number of subjects: 120
Study 33220004 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser
Number of subjects: 120
Study 33220004 — intervention group
Group type: EXPERIMENTAL
Intervention: BAG + Er:YAG laser
Number of subjects: 120
Study 33220004 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser + BAG
Number of subjects: 120
Study 33220004 — intervention group
Group type: COMPARATOR
Intervention: Deionized water (Control)
Number of subjects: 120
Study 36172861 — intervention group
Group type: EXPERIMENTAL
Intervention: Quarterly antibiotic-prescribing feedback reports
Number of subjects: 340
Study 36172861 — intervention group
Group type: COMPARATOR
Intervention: Control group (no feedback)
Number of subjects: 340
Study 33871558 — intervention group
Group type: EXPERIMENTAL
Intervention: LEU-PRO (3 g leucine, 10 g protein; n=38)
Number of subjects: 107
Study 33871558 — intervention group
Group type: EXPERIMENTAL
Intervention: LEU-PRO+n-3 (0.8 g EPA, 1.1 g DHA; n=38)
Number of subjects: 107
Study 33871558 — intervention group
Group type: COMPARATOR
Intervention: CON (isoenergetic control; n=31)
Number of subjects: 107
Study 32868798 — intervention group
Group type: EXPERIMENTAL
Intervention: MTX plus rhTNFR:Fc for 52 weeks
Number of subjects: 89
Study 32868798 — intervention group
Group type: EXPERIMENTAL
Intervention: MTX plus rhTNFR:Fc for 24 weeks
Number of subjects: 89
Study 32868798 — intervention group
Group type: COMPARATOR
Intervention: MTX monotherapy
Number of subjects: 89
Study 35683566 — intervention group
Group type: EXPERIMENTAL
Intervention: Electromyographic biofeedback (EMG-BF) added to conventional rehabilitation program
Number of subjects: 131
Study 35683566 — intervention group
Group type: COMPARATOR
Intervention: Conventional rehabilitation program without EMG-BF
Number of subjects: 131
Study 32507027 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Variable Stepping Training (HV)
Number of subjects: 50
Study 32507027 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Forward Walking Training (HF)
Number of subjects: 50
Study 32507027 — intervention group
Group type: COMPARATOR
Intervention: Low-Intensity Variable Stepping Training (LV)
Number of subjects: 50
Study 33433151 — intervention group
Group type: COMPARATOR
Intervention: High‐intensity interval exercise (HIIE)
Number of subjects: 10
Study 33433151 — intervention group
Group type: COMPARATOR
Intervention: Circuit resistance exercise (CRE)
Number of subjects: 10
Study 33433151 — intervention group
Group type: COMPARATOR
Intervention: Moderate‐intensity continuous exercise (MICE)
Number of subjects: 10
Study 34309743 — intervention group
Group type: EXPERIMENTAL
Intervention: Early Start Denver Model (ESDM) intervention for two years
Number of subjects: 0
Study 34309743 — intervention group
Group type: COMPARATOR
Intervention: Community resources (Control)
Number of subjects: 0
Study 33657333 — intervention group
Group type: EXPERIMENTAL
Intervention: Research articles reporting an intervention
Number of subjects: 537
Study 33657333 — intervention group
Group type: COMPARATOR
Intervention: Research articles including a comparison
Number of subjects: 537
Study 33657333 — intervention group
Group type: EXPERIMENTAL
Intervention: Articles with identified research methodology
Number of subjects: 537
Study 33657333 — intervention group
Group type: COMPARATOR
Intervention: Random assignment to experimental or control conditions
Number of subjects: 537
Study 33657333 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative inquiry methodology
Number of subjects: 537
Study 32483861 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioelectric impedance spectroscopy (BIS)
Number of subjects: 508
Study 32483861 — intervention group
Group type: COMPARATOR
Intervention: Tape measure (TM)
Number of subjects: 508
Study 36444922 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative thromboelastography (TEG)
Number of subjects: 284
Study 33048249 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning algorithm predicting ODI after treatment
Number of subjects: 60
Study 33048249 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of actual patient values after 6 months with predictions for alternative therapy
Number of subjects: 60
Study 32583971 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational video and booklet
Number of subjects: 221
Study 32583971 — intervention group
Group type: COMPARATOR
Intervention: Booklet alone
Number of subjects: 221
Study 35715180 — intervention group
Group type: EXPERIMENTAL
Intervention: SMART Mental Health intervention integrating a community-level stigma reduction campaign and task sharing with a mobile-enabled electronic decision support system (EDSS)
Number of subjects: 0
Study 35715180 — intervention group
Group type: COMPARATOR
Intervention: Control clusters (not specified what the control intervention is)
Number of subjects: 0
Study 35010577 — intervention group
Group type: EXPERIMENTAL
Intervention: Differential Learning (DL) with external focus
Number of subjects: 40
Study 35010577 — intervention group
Group type: EXPERIMENTAL
Intervention: Differential Learning (DL) with internal focus
Number of subjects: 40
Study 35010577 — intervention group
Group type: EXPERIMENTAL
Intervention: Differential Learning (DL) with no focus
Number of subjects: 40
Study 35010577 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional training with external focus
Number of subjects: 40
Study 35010577 — intervention group
Group type: COMPARATOR
Intervention: Traditional training with control groups
Number of subjects: 40
Study 36135380 — intervention group
Group type: EXPERIMENTAL
Intervention: CCP with nAb titers of >1:640 (high-titer group)
Number of subjects: 55
Study 36135380 — intervention group
Group type: COMPARATOR
Intervention: CCP with nAb titers of ≥1:160 to 1:640 (standard-titer group)
Number of subjects: 55
Study 33764167 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute dietary nitrate supplementation (high nitrate beverage)
Number of subjects: 11
Study 33764167 — intervention group
Group type: COMPARATOR
Intervention: Placebo (nitrate depleted beverage)
Number of subjects: 11
Study 33764167 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental stress challenge
Number of subjects: 11
Study 32332590 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy with music (CBT-music)
Number of subjects: 83
Study 32332590 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 83
Study 35088219 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention
Number of subjects: 1299
Study 35088219 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 1299
Study 33400421 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrafol® Women’s Balance Capsules
Number of subjects: 70
Study 33400421 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 35822412 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg esomeprazole magnesium (test)
Number of subjects: 75
Study 35822412 — intervention group
Group type: COMPARATOR
Intervention: 40 mg esomeprazole magnesium (reference)
Number of subjects: 75
Study 35822412 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole administered while fed
Number of subjects: 75
Study 32853704 — intervention group
Group type: EXPERIMENTAL
Intervention: Naturalistic developmental/behavioral intervention style, 25 hours per week for 12 months
Number of subjects: 87
Study 32853704 — intervention group
Group type: EXPERIMENTAL
Intervention: Naturalistic developmental/behavioral intervention style, 15 hours per week for 12 months
Number of subjects: 87
Study 32853704 — intervention group
Group type: EXPERIMENTAL
Intervention: Discrete trial teaching intervention style, 25 hours per week for 12 months
Number of subjects: 87
Study 32853704 — intervention group
Group type: EXPERIMENTAL
Intervention: Discrete trial teaching intervention style, 15 hours per week for 12 months
Number of subjects: 87
Study 32853704 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment intensity (25 hours per week)
Number of subjects: 87
Study 32853704 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment intensity (15 hours per week)
Number of subjects: 87
Study 36043033 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictive nursing with early active function exercise
Number of subjects: 80
Study 36043033 — intervention group
Group type: COMPARATOR
Intervention: Basic nursing methods only (control)
Number of subjects: 80
Study 33001255 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily probiotic group (Lactobacillus paracasei SD1 once daily)
Number of subjects: 268
Study 33001255 — intervention group
Group type: EXPERIMENTAL
Intervention: Triweekly probiotic group (Lactobacillus paracasei SD1 3 days a week)
Number of subjects: 268
Study 33001255 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 268
Study 34329355 — intervention group
Group type: EXPERIMENTAL
Intervention: Couple Oriented Counselling (COC)
Number of subjects: 484
Study 34329355 — intervention group
Group type: COMPARATOR
Intervention: Classical counselling
Number of subjects: 484
Study 33074709 — intervention group
Group type: EXPERIMENTAL
Intervention: Tauroursodeoxycholic acid (TUDCA) 1,500 mg
Number of subjects: 12
Study 33074709 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 33074709 — intervention group
Group type: EXPERIMENTAL
Intervention: Tauroursodeoxycholic acid (TUDCA)
Number of subjects: 12
Study 34455355 — intervention group
Group type: EXPERIMENTAL
Intervention: Unedited selfies with labels
Number of subjects: 350
Study 34455355 — intervention group
Group type: COMPARATOR
Intervention: Edited selfies
Number of subjects: 350
Study 36389724 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-PD-1 adjuvant therapy (intravenous injection of 200 mg, repeated every 3 weeks for a total of 4 or 8 cycles)
Number of subjects: 0
Study 36389724 — intervention group
Group type: COMPARATOR
Intervention: Control group (no anti-PD-1 therapy)
Number of subjects: 0
Study 36389724 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-PD-1 adjuvant therapy
Number of subjects: 0
Study 34349378 — intervention group
Group type: EXPERIMENTAL
Intervention: CMAC video laryngoscope (Mac 3)
Number of subjects: 87
Study 34349378 — intervention group
Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 87
Study 34781136 — intervention group
Group type: EXPERIMENTAL
Intervention: 1500 IU nano-encapsulated vitamin D fortified yogurt
Number of subjects: 139
Study 34781136 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 139
Study 35309285 — intervention group
Group type: EXPERIMENTAL
Intervention: LAMA/LABA
Number of subjects: 6266
Study 35309285 — intervention group
Group type: COMPARATOR
Intervention: LAMA/LABA/ICS
Number of subjects: 6266
Study 33218502 — intervention group
Group type: EXPERIMENTAL
Intervention: Core stabilization exercises
Number of subjects: 32
Study 33218502 — intervention group
Group type: COMPARATOR
Intervention: Transcutaneous electrical nerve stimulation and hot-pack (Control)
Number of subjects: 32
Study 36011661 — intervention group
Group type: EXPERIMENTAL
Intervention: Graphic message on health rewards
Number of subjects: 362
Study 36011661 — intervention group
Group type: EXPERIMENTAL
Intervention: Graphic message on social norms
Number of subjects: 362
Study 36011661 — intervention group
Group type: EXPERIMENTAL
Intervention: Graphic message on autonomy
Number of subjects: 362
Study 36011661 — intervention group
Group type: EXPERIMENTAL
Intervention: Graphic message on financial rewards
Number of subjects: 362
Study 32360038 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous Coronary Intervention (PCI) with everolimus‐eluting stents
Number of subjects: 1893
Study 32360038 — intervention group
Group type: COMPARATOR
Intervention: Coronary Artery Bypass Grafting (CABG)
Number of subjects: 1893
Study 32360038 — intervention group
Group type: EXPERIMENTAL
Intervention: Current smokers
Number of subjects: 1893
Study 32360038 — intervention group
Group type: EXPERIMENTAL
Intervention: Former smokers
Number of subjects: 1893
Study 32360038 — intervention group
Group type: EXPERIMENTAL
Intervention: Never smokers
Number of subjects: 1893
Study 35429132 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxcarbazepine (OXC)
Number of subjects: 271
Study 35429132 — intervention group
Group type: COMPARATOR
Intervention: Levetiracetam (LEV)
Number of subjects: 271
Study 33533681 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate ability discrepancy partner (MP)
Number of subjects: 176
Study 33533681 — intervention group
Group type: COMPARATOR
Intervention: Individual no-partner control
Number of subjects: 176
Study 32312223 — intervention group
Group type: EXPERIMENTAL
Intervention: Evolocumab
Number of subjects: 27564
Study 34705136 — intervention group
Group type: EXPERIMENTAL
Intervention: Water Exchange (WE)
Number of subjects: 284
Study 34705136 — intervention group
Group type: COMPARATOR
Intervention: Air Insufflation (C)
Number of subjects: 284
Study 33144712 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep brain stimulation (DBS)
Number of subjects: 100
Study 34763295 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 30
Study 34763295 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilates
Number of subjects: 30
Study 34763295 — intervention group
Group type: COMPARATOR
Intervention: Pelvic Floor Muscle Training (PFMT)
Number of subjects: 30
Study 34291862 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone fundoscopy (D‐eye or iExaminer)
Number of subjects: 102
Study 34291862 — intervention group
Group type: COMPARATOR
Intervention: Direct ophthalmoscopy (Welch Allyn)
Number of subjects: 102
Study 34291862 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone fundoscopy
Number of subjects: 102
Study 34291862 — intervention group
Group type: EXPERIMENTAL
Intervention: E-learning support
Number of subjects: 102
Study 35136033 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 2040
Study 35136033 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 2040
Study 35136033 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 2040
Study 35136033 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 2040
Study 35136033 — intervention group
Group type: EXPERIMENTAL
Intervention: Ziprasidone
Number of subjects: 2040
Study 35136033 — intervention group
Group type: EXPERIMENTAL
Intervention: First-generation antipsychotics (haloperidol or perphenazine)
Number of subjects: 2040
Study 35136033 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of PRS and clinical data
Number of subjects: 2040
Study 33539993 — intervention group
Group type: EXPERIMENTAL
Intervention: FBT plus Parent‐focused CRT
Number of subjects: 54
Study 33539993 — intervention group
Group type: EXPERIMENTAL
Intervention: FBT plus Adolescent‐focused CRT
Number of subjects: 54
Study 33539993 — intervention group
Group type: COMPARATOR
Intervention: FBT only
Number of subjects: 54
Study 33618070 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific Memory Attention Resource and Training (SMART) application, 10 min per day, five days per week for three months.
Number of subjects: 80
Study 33618070 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned).
Number of subjects: 80
Study 32573161 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed platform prosthesis
Number of subjects: 86
Study 32573161 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile platform prosthesis
Number of subjects: 86
Study 35113330 — intervention group
Group type: EXPERIMENTAL
Intervention: Orsiro ultrathin struts biodegradable polymer sirolimus‐eluting stents (O‐SES)
Number of subjects: 49
Study 35113330 — intervention group
Group type: COMPARATOR
Intervention: Xience thin struts durable polymer everolimus‐eluting stents (X‐EES)
Number of subjects: 49
Study 34509613 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Visits (VV)
Number of subjects: 442
Study 34509613 — intervention group
Group type: COMPARATOR
Intervention: In-person visits
Number of subjects: 442
Study 34509613 — intervention group
Group type: COMPARATOR
Intervention: Crossover (randomized to virtual but completed in-person)
Number of subjects: 442
Study 35500260 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional anesthesia
Number of subjects: 0
Study 35500260 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 0
Study 34655859 — intervention group
Group type: EXPERIMENTAL
Intervention: Fat-negative media content
Number of subjects: 525
Study 34655859 — intervention group
Group type: COMPARATOR
Intervention: Fat-positive media content
Number of subjects: 525
Study 35466432 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate skin-to-skin contact with a parent for the first six postnatal hours
Number of subjects: 91
Study 35466432 — intervention group
Group type: COMPARATOR
Intervention: Standard incubator care
Number of subjects: 91
Study 33544305 — intervention group
Group type: EXPERIMENTAL
Intervention: Galcanezumab 120 mg with a 240 mg loading dose
Number of subjects: 2886
Study 33544305 — intervention group
Group type: EXPERIMENTAL
Intervention: Galcanezumab 240 mg
Number of subjects: 2886